Document and Entity Information
Document and Entity Information - shares | 3 Months Ended | |
Mar. 31, 2021 | May 10, 2021 | |
Details | ||
Registrant CIK | 0001342936 | |
Fiscal Year End | --12-31 | |
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Period End Date | Mar. 31, 2021 | |
Document Transition Report | false | |
Entity File Number | 000-52390 | |
Entity Registrant Name | Advanced Voice Recognition Systems, Inc. | |
Entity Incorporation, State or Country Code | NV | |
Entity Tax Identification Number | 98-0511932 | |
Entity Address, Address Line One | 7659 E. Wood Drive, | |
Entity Address, City or Town | Scottsdale, | |
Entity Address, State or Province | AZ | |
Entity Address, Postal Zip Code | 85260 | |
City Area Code | (480) | |
Local Phone Number | 704-4183 | |
Title of 12(b) Security | Common Stock par value $0.001 per share | |
Trading Symbol | AVOI | |
Security Exchange Name | NONE | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Non-accelerated Filer | |
Entity Small Business | true | |
Entity Emerging Growth Company | true | |
Entity Ex Transition Period | false | |
Entity Shell Company | false | |
Entity Common Stock, Shares Outstanding | 280,386,935 | |
Amendment Flag | false | |
Document Fiscal Year Focus | 2021 | |
Document Fiscal Period Focus | Q1 |
Condensed Balance Sheets (Unaud
Condensed Balance Sheets (Unaudited)) - USD ($) | Mar. 31, 2021 | Dec. 31, 2020 |
Current Assets | ||
Cash and cash equivalents | $ 1,340 | $ 348 |
Total Current Assets | 1,340 | 348 |
Non-Current Assets | ||
Patent, net | 10,308 | 13,984 |
Total Non-Current Assets | 10,308 | 13,984 |
Total Assets | 11,648 | 14,332 |
Current Liabilities | ||
Accounts payable | 90,315 | 78,144 |
Payroll | 162,382 | 162,382 |
Note Payable AIP | 19,935 | 19,935 |
Advance Related Party | 8,079 | 4,533 |
Accrued Interest | 12,460 | 11,961 |
Total Current Liabilities | 293,171 | 276,955 |
Total Liabilities and Stockholders' Deficit | 11,648 | 14,332 |
Total Liabilities | 293,171 | 276,955 |
Common stock | 280,387 | 280,387 |
Additional paid-in capital | 7,957,033 | 7,957,033 |
Accumulated Deficit | (8,518,943) | (8,500,043) |
Total Stockholders' Deficit | $ (281,523) | $ (262,623) |
Condensed Balance Sheets (Una_2
Condensed Balance Sheets (Unaudited)) - Parenthetical - $ / shares | Mar. 31, 2021 | Dec. 31, 2020 |
Details | ||
Common Stock, Par or Stated Value Per Share | $ 0.001 | $ 0.001 |
Common Stock, Shares Authorized | 547,500,000 | 547,500,000 |
Common Stock, Shares, Issued | 280,220,268 | 280,220,268 |
Common Stock, Shares, Outstanding | 278,220,268 | 278,220,268 |
Condensed Statements of Operati
Condensed Statements of Operations (Unaudited) - USD ($) | 3 Months Ended | |
Mar. 31, 2021 | Mar. 31, 2020 | |
Details | ||
Sales | $ 0 | $ 0 |
Cost of goods sold | 0 | 0 |
Gross profit | 0 | 0 |
Operating expenses: | ||
Compensation | 69 | 7,794 |
Professional fees | 11,825 | 21,346 |
Office | 5,936 | 6,065 |
Other | 557 | 357 |
Total operating expenses | 18,387 | 35,562 |
Loss from operations | (18,387) | (35,562) |
Other income and (expense): | ||
Interest expense | (513) | (498) |
Net other expense | (513) | (498) |
Loss before income taxes | (18,900) | (36,060) |
Provision for income taxes | 0 | 0 |
Net Loss | $ (18,900) | $ (36,060) |
Basic and diluted loss per common share | $ 0 | $ 0 |
Weighted average number of common shares | 280,386,935 | 279,670,817 |
Condensed Statement of Stockhol
Condensed Statement of Stockholders' Deficit (Unaudited) - USD ($) | Common Stock | Additional Paid-in Capital | Retained Earnings | Total |
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Dec. 31, 2019 | $ 278,220 | $ 7,936,600 | $ (8,418,514) | $ (203,694) |
Shares, Outstanding, Beginning Balance at Dec. 31, 2019 | 278,220,268 | |||
Stock Issued During Period, Value, Purchase of Assets | $ 1,500 | 13,500 | 0 | 15,000 |
Stock Issued During Period, Shares, Purchase of Assets | 1,500,000 | |||
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $ 0 | 0 | (36,060) | (36,060) |
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Mar. 31, 2020 | $ 279,720 | 7,950,100 | (8,454,574) | (224,754) |
Shares, Outstanding, Ending Balance at Mar. 31, 2020 | 279,720,268 | |||
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Dec. 31, 2020 | $ 280,387 | 7,957,033 | (8,500,043) | (262,623) |
Shares, Outstanding, Beginning Balance at Dec. 31, 2020 | 280,386,935 | |||
Stock Issued During Period, Value, Purchase of Assets | $ 0 | 0 | 0 | 0 |
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | 0 | 0 | (18,900) | (18,900) |
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Mar. 31, 2021 | $ 280,387 | $ 7,957,033 | $ (8,518,943) | $ (281,523) |
Shares, Outstanding, Ending Balance at Mar. 31, 2021 | 280,386,935 |
Condensed Statements of Cash Fl
Condensed Statements of Cash Flows (Unaudited) - USD ($) | 3 Months Ended | |
Mar. 31, 2021 | Mar. 31, 2020 | |
Cash Flows from Operating Activities: | ||
Net loss | $ (18,900) | $ (36,060) |
Adjustments to reconcile net loss to net cash used in operating activities: | ||
Amortization and depreciation | 3,676 | 3,676 |
Changes in operating liabilities: | ||
Accounts payable and accrued liabilities | 12,670 | 12,873 |
Net cash used in operating activities | (2,554) | (19,511) |
Cash Flows from Financing Activities: | ||
Proceeds from sale of common stock | 0 | 15,000 |
Advance from related party | 3,546 | 0 |
Net cash provided by financing activities | 3,546 | 15,000 |
Net change in cash | 992 | (4,511) |
Cash and Cash Equivalents, at Carrying Value, Beginning Balance | 348 | 6,241 |
Cash and Cash Equivalents, at Carrying Value, Ending Balance | 1,340 | 1,730 |
Supplemental Disclosure of Cash Flow Information: | ||
Interest | 499 | 498 |
Income taxes | $ 0 | $ 0 |
Note 1. Nature of Operations
Note 1. Nature of Operations | 3 Months Ended |
Mar. 31, 2021 | |
Notes | |
Note 1. Nature of Operations | Note 1. Nature of Operations Company Overview The operations of Advanced Voice Recognition Systems, Inc. (“AVRS” or the “Company”), http://www.avrsys.com, commenced in 1994 with a predecessor entity called NCC, Inc. NCC, Inc. was incorporated on March 15, 1994 in the State of Ohio. NCC, Inc. operated as a software and hardware development company that marketed voice recognition and transcription products for commercial applications. In May 2000, WG Investments, LLC acquired the assets of NCC, Inc. and subsequently changed its name to NCC, LLC. NCC, LLC (also a predecessor to AVRS) continued the operations of NCC, Inc. until approximately December 31, 2001, when shifts in the industry’s markets caused NCC, LLC to suspend its operations. AVRS was incorporated in the State of Colorado on July 7, 2005. In September 2005, the members of NCC, LLC transferred all of their membership interests in NCC, LLC to AVRS in exchange for 93,333,333 shares (post-recapitalization) of AVRS common stock. In December 2005, the Board of Directors approved a 1.5-to-1 stock split issuing 46,666,667 common shares (post-recapitalization), which increased the number of common shares outstanding to 140 million shares (post-capitalization). Following the incorporation of AVRS, the Company initiated a new business plan and intends to continue its operations in the voice recognition and transcription industry. AVRS is a software development company specializing in speech recognition technologies. AVRS has successfully obtained patent protection of its proprietary technology (refer to Note 3, Intangible Assets). The Company has currently engaged a firm to investigate and assert claims relating to certain patents including negotiating licensing agreements and the filing and prosecution of lawsuits. Stock Purchase Agreements During the three months ended March 31, 2021, the Company did not enter into any Stock Purchase Agreements and no payments were received. During the year ended December 31, 2020 the Company entered into Stock Purchase Agreements for the private sale to four persons or entities of an aggregate of 2,166,667 shares of the common stock for aggregate proceeds of $22,600, full payment of which was received in the period. Commitments and Contingencies On April 20, 2015 Advanced Voice Recognition Systems, Inc. (“AVRS”) entered into a Material Letter Agreement with an unrelated third party (“AIP”) in which they promise to pay to patent legal counsel funds to continue prosecuting Patents on behalf of AVRS. AVRS promises to pay AIP, or to such other holder of this promissory note (Note) as designate, the principal, together with a premium of ten percent (10%) of Principle and two percent (2%) of proceeds received by Company from a Monetization Event initiated by AIP. Interest was accrued and reported at March 31, 2021. On November 1, 2016, Advanced Voice Recognition Systems, Inc. (“ AVRS Agreement Patent Rights On June 21, 2018, Advanced Voice Recognition Systems, Inc. (“ AVRS Agreement the Firm On July 22, 2019 Apple, Inc. submitted a petition for Inter Partes Review (IPR) of the AVRS patent. It was ordered in the case of AVRS, Inc. v. Apple Inc (Case No. 2-18-cv-2083) that the parties’ stipulation was granted and the case is stayed pending the resolution of the IPR proceeding. Buether Joe and Carpenter, LLC (BJC), our representation in the AVRS v. Apple litigation represents AVRS in the IPR. The IPR response to the Patent Trial and Appeal Board (PTAB) was done November 8, 2019. On January 13, 2021, the United States Patent and Trademark Office Patent Trial and Appeal Board (PTAB) issued a Final Written Decision under 35 U.S.C. § 318(a) in Inter Partes Review |
Note 2. Significant Accounting
Note 2. Significant Accounting Policies | 3 Months Ended |
Mar. 31, 2021 | |
Notes | |
Note 2. Significant Accounting Policies | Note 2. Significant Accounting Policies Unaudited Financial Information The accompanying financial information at March 31 2021 and for the three months ended March 31, 2021 and 2020 is unaudited. In the opinion of management, all normal and recurring adjustments which are necessary to provide a fair presentation of the Company’s financial position at March 31, 2021 and its operating results for the three months ended March 31, 2021 and 2020 have been made. Certain information and footnote data necessary for a fair presentation of financial position and results of operations in conformity with accounting principles generally accepted in the United States of America have been condensed or omitted. It is therefore suggested that these financial statements be read in conjunction with the summary of significant accounting policies and notes to financial statements included in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission (the “SEC”) for the year ended December 31, 2020. The results of operations for the three months ended March 31, 2021 are not necessarily an indication of operating results to be expected for the year ending December 31, 2021. Going Concern The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. Liabilities exceed assets and there is a capital deficiency of $281,523 and no significant revenues. The Company may be unable to continue as a going concern for a reasonable period of time. The financial statements do not include any adjustments relating to the recoverability and classification of assets and liabilities that might be necessary should the Company be unable to continue as a going concern. The Company’s continuation as a going concern is dependent upon its ability to generate sufficient cash flow to meet its obligations on a timely basis and ultimately to attain profitability. During the twelve months ended December 31, 2020 the Company received an aggregate of $22,600 from the sale of shares in private offerings of its common stock. During the three months ended March 31, 2021, the Company did not enter into any Stock Purchase Agreements and no payments were received. The Company’s current operations are related to patent monetization and filing of additional patents. The Company has entered into a letter agreement with Dominion Harbor Group, LLC to provide strategic advisory services to AVRS. Dominion has agreed to advanced costs up to an aggregate of $10,000,000. On June 28, 2017 the Company and Dominion agreed to terminate the August 20, 2015 Letter Agreement. The Company did not incur any material early termination penalties. In addition, the Company has revised the Contingent Fee Agreement with Buether Joe & Carpenter, LLC which will represent AVRS in connection with investigating and asserting claims to the AVRS patents including licensing and litigation activities. Any and all advanced costs will only become liabilities if successful. On June 6, 2017 AVRS and BJC revised the Contingent Fee Agreement as it related to the termination of the August 20, 2015 Dominion Harbor Letter Agreement. There is no guarantee that AVRS will be able to provide the capital required for the Company to continue as a going concern. Use of Estimates The preparation of financial statements in accordance with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Cash and Cash Equivalents The Company considers all highly liquid debt instruments with original maturities of three months or less when acquired to be cash equivalents. The Company had cash at March 31, 2021 of $1,340, and $348 at December 31, 2020. No amounts resulted from cash equivalents. |
Note 3. Intangible and Fixed As
Note 3. Intangible and Fixed Assets | 3 Months Ended |
Mar. 31, 2021 | |
Notes | |
Note 3. Intangible and Fixed Assets | Note 3. Intangible and Fixed Assets Intangible Assets The Company monitors the anticipated outcome of legal actions, and if it determines that the success of the defense of a patent is probable, and so long as the Company believes that the future economic benefit of the patent will be increased, the Company capitalizes external legal costs incurred in the defense of the patent. Upon successful defense of litigation, the amounts previously capitalized are amortized over the remaining life of the patent. On July 7, 2009, U.S. Patent # 7,558,730, entitled “Speech Recognition and Transcription Among Users Having Heterogeneous Protocols,” was issued by the U.S. Patent and Trademark Office. In accordance with 35 U.S.C. 154, the patent shall be for a term beginning on July 7, 2009 and ending 20 years from the application date of November 27, 2001, or November 27, 2021. The deferred fees were capitalized during the quarter ended September 30, 2009 and the Company began amortization. AVRS filed a Complaint in the United States District Court Northern District for Arizona (Case No. 2-18-cv-2083) on July 3, 2018, and alleges that Apple products infringe U.S. Patent No. 7,558,730 entitled “Speech Recognition and Transcription Among Users Having Heterogeneous Protocols” (the “‘730 Patent”). On May 24, 2011, U.S. Patent #7,949,534, entitled “Speech Recognition and Transcription Among Users Having Heterogeneous Protocols,” was issued by the U.S. Patent and Trademark Office. In accordance with 35 U.S.C. 154, the patent shall be for a term beginning May 24, 2011 and ending 20 years from the application date of the parent application (U.S. Patent #7,558,730) of November 27, 2001, or November 27, 2021. The deferred fees were capitalized during the quarter ended June 30, 2011 and the Company began amortization. On March 6, 2012, U.S. Patent #8,131,557, entitled “Speech Recognition and Transcription Among Users Having Heterogeneous Protocols,” was issued by the U.S. Patent and Trademark Office. In accordance with 35 U.S.C. 154, the patent shall be for a term beginning March 6, 2012 and ending 20 years from the application date of the parent application (U.S. Patent #7,558,730) of November 27, 2001, or November 27, 2021. The deferred fees were capitalized during the quarter ended March 31, 2012 and the Company began amortization. On July 30, 2013, U.S. Patent #8,498,871, entitled “Dynamic Speech Recognition and Transcription Among Users Having Heterogeneous Protocols,” was issued by the U.S. Patent and Trademark Office. In accordance with 35 U.S.C. 154, the patent shall be for a term beginning on July 30, 2013 and ending 20 years from the application date of November 27, 2001, or November 27, 2021. The deferred fees were capitalized during the quarter ended September 30, 2013 and the Company began amortization. On September 22, 2015, U.S. Patent #9,142,217, entitled “Speech Recognition and Transcription Among Users Having Heterogeneous Protocols,” was issued by the U.S. Patent and Trademark Office. In accordance with 35 U.S.C. 154, the patent shall be for a term beginning September 22, 2015 and ending 20 years from the application date of the parent application (US Patent No. 7,558,730) of November 27, 2001, or November 27, 2021. The deferred fees were capitalized during the quarter ended September 30, 2015 and the Company began amortization. On April 3, 2018, U.S. Patent #9,934,786, entitled “Speech Recognition and Transcription Among Users Having Heterogeneous Protocols,” was issued by the U.S. Patent and Trademark Office. In accordance with 35 U.S.C. 154, the patent shall be for a term beginning April 3, 2018 and ending 20 years from the application date of the parent application (U.S. Patent #7,558,730) of November 27, 2001 or November 27, 2021. The deferred costs were capitalized during the quarter ended June 30, 2018 and the Company began amortization. Amortization at December 31, 2020 is as follows: SCHEDULE OF INTANGIBLE ASSETS Ended December 31, 2020 U.S. Patent # Carrying Value Amortization Balance 7,558,730 $ 58,277 53,958 4,319 7,949,534 3,365 3,052 313 8,131,557 5,092 4,612 480 8,498,871 21,114 18,779 2,335 9,142,217 35,068 29,674 5,394 9,934,786 4,575 3,432 1,143 $ 127,491 $ 113,507 $ 13,984 Amortization at March 31, 2021 is as follows: Ended March 31, 2021 U.S. Patent # Carrying Value Amortization Balance 7,558,730 $ 58,277 55,131 3,146 7,949,534 3,365 3,130 235 8,131,557 5,092 4,743 349 8,498,871 21,114 19,412 1,702 9,142,217 35,068 31,023 4,045 9,934,786 4,575 3,744 831 $ 127,491 $ 117,183 $ 10,308 Amortization expense totaled $3,676 for each of the three months ended March 31, 2021 and 2020 respectively. Estimated aggregate amortization expense for each of the next year is as follows: SCHEDULE OF FUTURE AMORTIZATION Year ending March 31, 2021 10,308 $ 10,308 |
Note 4. Related Party Transacti
Note 4. Related Party Transactions | 3 Months Ended |
Mar. 31, 2021 | |
Notes | |
Note 4. Related Party Transactions | Note 4. Related Party Transactions Related Parties Transactions and Indebtedness The Company owed the officers aggregate of $162,382 at March 31, 2021 and December 31, 2020 for accrued payroll. During the period of three months ending March 31, 2021, March 31, 2020 the Company paid gross payroll of $69 and $7,794 for payroll expenses. At March 31, 2021 the Secretary Treasurer advanced the Company $8,079 for operating expenses. |
Note 5. Note Payable & Accounts
Note 5. Note Payable & Accounts Payable | 3 Months Ended |
Mar. 31, 2021 | |
Notes | |
Note 5. Note Payable & Accounts Payable | Note 5. Note Payable & Accounts Payable On April 20, 2015, the Company entered into a Material Letter Agreement with an unrelated third-party AIP” in which they promise to pay to patent legal counsel funds to continue prosecuting Patents on behalf of AVRS. AVRS promises to pay AIP, or to such other holder of this promissory note (Note) as designate, the principal, together with a premium of ten percent (10%) of Principle and two percent (2%) of proceeds received by Company from a Monetization Event initiated by AIP. Interest was accrued and reported at March 31, 2021. On September 24, 2018, the Company, entered into Promissory Note with Walter Geldenhuys, who is our President, Chief Executive Officer and Chief Financial Officer, and who serves as a member of our Board of Directors. The Promissory Note is effective as of September 24, 2018 in the principal amount of $9,000 with a maturity date of the Promissory Note September 24, 2019. Interest at 4% per annum was charged and accrued at December 31, 2018. The Company repaid $2,500 of the note on December 10, 2018. During 2019 the Company repaid $6,500, paying the note in full on December 27, 2019. Interest at 4% per annum was charged and accrued at December 31, 2019. Accrued interest of $254 was paid on February 28, 2020. |
Note 6. Stockholder Equity _ (D
Note 6. Stockholder Equity / (Deficit) | 3 Months Ended |
Mar. 31, 2021 | |
Notes | |
Note 6. Stockholder Equity / (Deficit) | Note 6. Stockholder Equity / (Deficit) The Company has issued shares of its common stock pursuant to certain agreements as described in Note 1. |
Note 7. Subsequent Events
Note 7. Subsequent Events | 3 Months Ended |
Mar. 31, 2021 | |
Notes | |
Note 7. Subsequent Events | Note 7. Subsequent Events Covid-19 also impacted Company funding. Our Secretary / Treasurer, Diana Jakowchuk, continues to advance the Company funds. As of May 10, 2021, Ms. Jakowchuk has advanced a total of $8,378.75. |
Note 2. Significant Accountin_2
Note 2. Significant Accounting Policies: Going Concern (Policies) | 3 Months Ended |
Mar. 31, 2021 | |
Policies | |
Going Concern | Going Concern The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. Liabilities exceed assets and there is a capital deficiency of $281,523 and no significant revenues. The Company may be unable to continue as a going concern for a reasonable period of time. The financial statements do not include any adjustments relating to the recoverability and classification of assets and liabilities that might be necessary should the Company be unable to continue as a going concern. The Company’s continuation as a going concern is dependent upon its ability to generate sufficient cash flow to meet its obligations on a timely basis and ultimately to attain profitability. During the twelve months ended December 31, 2020 the Company received an aggregate of $22,600 from the sale of shares in private offerings of its common stock. During the three months ended March 31, 2021, the Company did not enter into any Stock Purchase Agreements and no payments were received. The Company’s current operations are related to patent monetization and filing of additional patents. The Company has entered into a letter agreement with Dominion Harbor Group, LLC to provide strategic advisory services to AVRS. Dominion has agreed to advanced costs up to an aggregate of $10,000,000. On June 28, 2017 the Company and Dominion agreed to terminate the August 20, 2015 Letter Agreement. The Company did not incur any material early termination penalties. In addition, the Company has revised the Contingent Fee Agreement with Buether Joe & Carpenter, LLC which will represent AVRS in connection with investigating and asserting claims to the AVRS patents including licensing and litigation activities. Any and all advanced costs will only become liabilities if successful. On June 6, 2017 AVRS and BJC revised the Contingent Fee Agreement as it related to the termination of the August 20, 2015 Dominion Harbor Letter Agreement. There is no guarantee that AVRS will be able to provide the capital required for the Company to continue as a going concern. |
Note 2. Significant Accountin_3
Note 2. Significant Accounting Policies: Use of Estimates (Policies) | 3 Months Ended |
Mar. 31, 2021 | |
Policies | |
Use of Estimates | Use of Estimates The preparation of financial statements in accordance with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. |
Note 2. Significant Accountin_4
Note 2. Significant Accounting Policies: Cash and Cash Equivalents (Policies) | 3 Months Ended |
Mar. 31, 2021 | |
Policies | |
Cash and Cash Equivalents | Cash and Cash Equivalents The Company considers all highly liquid debt instruments with original maturities of three months or less when acquired to be cash equivalents. The Company had cash at March 31, 2021 of $1,340, and $348 at December 31, 2020. No amounts resulted from cash equivalents. |
Note 3. Intangible and Fixed _2
Note 3. Intangible and Fixed Assets: Schedule of Amortization of Intangible Assets (Tables) | 3 Months Ended |
Mar. 31, 2021 | |
Tables/Schedules | |
Schedule of Amortization of Intangible Assets | SCHEDULE OF INTANGIBLE ASSETS Ended December 31, 2020 U.S. Patent # Carrying Value Amortization Balance 7,558,730 $ 58,277 53,958 4,319 7,949,534 3,365 3,052 313 8,131,557 5,092 4,612 480 8,498,871 21,114 18,779 2,335 9,142,217 35,068 29,674 5,394 9,934,786 4,575 3,432 1,143 $ 127,491 $ 113,507 $ 13,984 Amortization at March 31, 2021 is as follows: Ended March 31, 2021 U.S. Patent # Carrying Value Amortization Balance 7,558,730 $ 58,277 55,131 3,146 7,949,534 3,365 3,130 235 8,131,557 5,092 4,743 349 8,498,871 21,114 19,412 1,702 9,142,217 35,068 31,023 4,045 9,934,786 4,575 3,744 831 $ 127,491 $ 117,183 $ 10,308 |
Note 3. Intangible and Fixed _3
Note 3. Intangible and Fixed Assets: Schedule of Future Amortization (Tables) | 3 Months Ended |
Mar. 31, 2021 | |
Tables/Schedules | |
Schedule of Future Amortization | SCHEDULE OF FUTURE AMORTIZATION Year ending March 31, 2021 10,308 $ 10,308 |
Note 2. Significant Accountin_5
Note 2. Significant Accounting Policies: Going Concern (Details) - USD ($) | 3 Months Ended | 12 Months Ended | |
Mar. 31, 2021 | Mar. 31, 2020 | Dec. 31, 2020 | |
Details | |||
Total Stockholders' Deficit | $ (281,523) | $ (262,623) | |
Proceeds from sale of common stock | $ 0 | $ 15,000 | $ 22,600 |
Note 2. Significant Accountin_6
Note 2. Significant Accounting Policies: Cash and Cash Equivalents (Details) - USD ($) | Mar. 31, 2021 | Dec. 31, 2020 | Mar. 31, 2020 | Dec. 31, 2019 |
Details | ||||
Cash and cash equivalents | $ 1,340 | $ 348 | $ 1,730 | $ 6,241 |
Note 3. Intangible and Fixed _4
Note 3. Intangible and Fixed Assets: Schedule of Amortization of Intangible Assets (Details) - USD ($) | Mar. 31, 2021 | Dec. 31, 2020 |
Carrying Value | $ 10,308 | $ 13,984 |
Balance | 10,308 | |
U.S. Patent # 7,558,730 | ||
Carrying Value | 58,277 | 58,277 |
Amortization | 55,131 | 53,958 |
Balance | 3,146 | 4,319 |
U.S. Patent # 7,949,534 | ||
Carrying Value | 3,365 | 3,365 |
Amortization | 3,130 | 3,052 |
Balance | 235 | 313 |
U.S. Patent # 8,131,557 | ||
Carrying Value | 5,092 | 5,092 |
Amortization | 4,743 | 4,612 |
Balance | 349 | 480 |
U.S. Patent # 8,498,871 | ||
Carrying Value | 21,114 | 21,114 |
Amortization | 19,412 | 18,779 |
Balance | 1,702 | 2,335 |
U.S. Patent # 9,142,217 | ||
Carrying Value | 35,068 | 35,068 |
Amortization | 31,023 | 29,674 |
Balance | 4,045 | 5,394 |
U.S. Patent # 9,934,786 | ||
Carrying Value | 4,575 | 4,575 |
Amortization | 3,744 | 3,432 |
Balance | $ 831 | $ 1,143 |
Note 3. Intangible and Fixed _5
Note 3. Intangible and Fixed Assets: Schedule of Future Amortization (Details) | Mar. 31, 2021USD ($) |
Details | |
2021 | $ 10,308 |
Balance | $ 10,308 |
Note 4. Related Party Transac_2
Note 4. Related Party Transactions (Details) - USD ($) | 3 Months Ended | |
Mar. 31, 2021 | Mar. 31, 2020 | |
Details | ||
Compensation | $ 69 | $ 7,794 |
Note 7. Subsequent Events (Deta
Note 7. Subsequent Events (Details) - USD ($) | 3 Months Ended | |
Mar. 31, 2021 | Dec. 31, 2020 | |
Advance Related Party | $ 8,079 | $ 4,533 |
Subsequent Event | ||
Subsequent Event, Date | May 10, 2021 | |
Subsequent Event, Description | Ms. Jakowchuk has advanced a total of $8,378.75. | |
Advance Related Party | $ 8,378.75 |